Artículos de revistas sobre el tema "BRCA testing"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "BRCA testing".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Parikh, Purvish M., J. Wadhwa, S. Minhas, A. Gupta, S. Mittal, S. Ranjan, P. Mehta et al. "Practical consensus recommendation on when to do BRCA testing". South Asian Journal of Cancer 07, n.º 02 (abril de 2018): 106. http://dx.doi.org/10.4103/sajc.sajc_112_18.
Texto completoSahnane, Nora, Ileana Carnevali, Giorgio Formenti, Jvan Casarin, Sofia Facchi, Raffaella Bombelli, Eleonora Di Lauro et al. "BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor". International Journal of Molecular Sciences 21, n.º 24 (19 de diciembre de 2020): 9708. http://dx.doi.org/10.3390/ijms21249708.
Texto completoMoore, H. C., R. Wesolowski, T. K. Choueiri, L. Rybicki, A. G. Shealy, G. Casey y D. Weng. "Therapeutic radiation for breast cancer in BRCA mutation carriers and contralateral breast cancer (CBC) risk". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 611. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.611.
Texto completoBrankovic-Magic, Mirjana, Jelena Dobricic, Radmila Jankovic, Irene Konstantopoulou, Drakoulis Yannoukakos y Sinisa Radulovic. "Identifying and testing for hereditary susceptibility to breast/ovarian cancer in Serbia: Where are we now?" Archive of Oncology 14, n.º 3-4 (2006): 131–35. http://dx.doi.org/10.2298/aoo0604131b.
Texto completoSchwartz, Zachary Phillip, Mae Zakhour, Andrew John Li, Christine S. Walsh, Bj Rimel, Monica Alvarado, Scott E. Lentz y Ilana Cass. "Comparison of risk-reducing surgery in women with BRCA and non-BRCA ovarian cancer susceptibility genes." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 1547. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.1547.
Texto completoHolter, Spring, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani et al. "Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma". Journal of Clinical Oncology 33, n.º 28 (1 de octubre de 2015): 3124–29. http://dx.doi.org/10.1200/jco.2014.59.7401.
Texto completoToss, Angela, Eleonora Molinaro, Marta Venturelli, Federica Domati, Luigi Marcheselli, Simonetta Piana, Elena Barbieri et al. "BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy". Cancers 12, n.º 5 (15 de mayo de 2020): 1252. http://dx.doi.org/10.3390/cancers12051252.
Texto completoShatavi, Seerin Viviane, Lindsay Dohany, Mohammad Muhsin Chisti, Ishmael A. Jaiyesimi y Dana Zakalik. "Unique genetic characteristics of BRCA mutation carriers in a cohort of Arab American women." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 1541. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1541.
Texto completoMatsubara, Nobuaki, Johann S. De Bono, David Olmos, Giuseppe Procopio, Satoru Kawakami, Yuksel Urun, Robbert J. van Alphen et al. "Olaparib efficacy in patients with metastatic castration-resistant prostate cancer (mCRPC) carrying circulating tumor (ct) DNA alterations in BRCA1, BRCA2 or ATM: Results from the PROfound study." Journal of Clinical Oncology 39, n.º 6_suppl (20 de febrero de 2021): 27. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.27.
Texto completoMurciano-Goroff, Yonina R., Alison M. Schram, Ezra Rosen, Yelena Y. Janjigian, Michael F. Berger, Mark Donoghue, Chaitanya Bandlamudi y Alexander E. Drilon. "BRCA reversion mutations in a pan-cancer cohort to reveal BRCA-dependence in select noncanonical BRCA-mutant histologies." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): 3012. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3012.
Texto completoSekine, Masayuki, Koji Nishino y Takayuki Enomoto. "Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location". Genes 12, n.º 7 (8 de julio de 2021): 1050. http://dx.doi.org/10.3390/genes12071050.
Texto completoRahman, Belinda, Anne Lanceley, Rebecca S. Kristeleit, Jonathan A. Ledermann, Michelle Lockley, Mary McCormack, Tim Mould y Lucy Side. "Mainstreamed genetic testing for women with ovarian cancer: first-year experience". Journal of Medical Genetics 56, n.º 3 (13 de marzo de 2018): 195–98. http://dx.doi.org/10.1136/jmedgenet-2017-105140.
Texto completoKapoor, Nimmi S., Lisa D. Curcio, Carlee A. Blakemore, Amy K. Bremner, Rachel E. McFarland, John G. West y Kimberly C. Banks. "Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer." Journal of Clinical Oncology 33, n.º 28_suppl (1 de octubre de 2015): 16. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.16.
Texto completoTrainer, Alison H., Bettina Meiser, Kaaren Watts, Gillian Mitchell, Kathy Tucker y Michael Friedlander. "Moving Toward Personalized Medicine: Treatment-Focused Genetic Testing of Women Newly Diagnosed With Ovarian Cancer". International Journal of Gynecologic Cancer 20, n.º 5 (junio de 2010): 704–16. http://dx.doi.org/10.1111/igc.0b013e3181dbd1a5.
Texto completoSalo-Mullen, Erin E., Eileen Mary O'Reilly, David Paul Kelsen, Maeve Aine Lowery, Kenneth H. Yu, Rohini Rau-Murthy, Beth Siegel et al. "Identification of germline genetic mutations in patients with pancreatic adenocarcinoma." Journal of Clinical Oncology 31, n.º 4_suppl (1 de febrero de 2013): 159. http://dx.doi.org/10.1200/jco.2013.31.4_suppl.159.
Texto completoImyanitov, Yevgeniy, Aleksey Belyaev, Aleksandr Shcherbakov, Lev Bershteyn, Aleksandr Bessonov, Petr Krivorotko, Tatyana Gorodnova et al. "PRESENCE OF BRCA1 AND BRCA2 IN HEALTHY WOMEN AND MEN: DNA TESTING, DIAGNOSTIC ACTIVITIES AND CANCER PREVENTION". Problems in oncology 63, n.º 2 (1 de febrero de 2017): 190–98. http://dx.doi.org/10.37469/0507-3758-2017-63-2-190-198.
Texto completoJung, J., E. Kang, J. M. Gwak, A. N. Seo, S. Y. Park, A. S. Lee, H. Baek, S. Chae, E. K. Kim y S. W. Kim. "Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients". Current Oncology 23, n.º 5 (26 de octubre de 2016): 298. http://dx.doi.org/10.3747/co.23.3054.
Texto completoMullai, N. "The importance of variants of unknown significance (VUS) in BRCA mutation." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): e22507-e22507. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e22507.
Texto completoAtchley, Deann P., Constance T. Albarracin, Adriana Lopez, Vicente Valero, Christopher I. Amos, Ana Maria Gonzalez-Angulo, Gabriel N. Hortobagyi y Banu K. Arun. "Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer". Journal of Clinical Oncology 26, n.º 26 (10 de septiembre de 2008): 4282–88. http://dx.doi.org/10.1200/jco.2008.16.6231.
Texto completoNeveling, Kornelia, Arjen R. Mensenkamp, Ronny Derks, Michael Kwint, Hicham Ouchene, Marloes Steehouwer, Bart van Lier et al. "BRCA Testing by Single-Molecule Molecular Inversion Probes". Clinical Chemistry 63, n.º 2 (1 de febrero de 2017): 503–12. http://dx.doi.org/10.1373/clinchem.2016.263897.
Texto completoLiu, Ying L., Julia Lindsay Boland, Karen Anne Cadoo, Claire Frances Friedman, Jason A. Konner, Roisin Eilish O'Cearbhaill, Carol Aghajanian y Dmitriy Zamarin. "Response to immune checkpoint inhibition and survival in BRCA-associated recurrent ovarian cancer." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 2615. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.2615.
Texto completoSpizzo, Gilbert, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey, Anthony Frank Shields, Sukeshi Patel Arora et al. "Frequency of BRCA mutation in biliary tract cancer and its correlation with tumor mutational burden (TMB) and microsatellite instability (MSI)." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 4085. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4085.
Texto completoOktay, Kutluk, Ja Yeon Kim, David Barad y Samir N. Babayev. "Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks". Journal of Clinical Oncology 28, n.º 2 (10 de enero de 2010): 240–44. http://dx.doi.org/10.1200/jco.2009.24.2057.
Texto completoArun, Banu, Angelica Gutierrez Barrera, Rachel M. Layman, Stephen K. Gruschkus, Isabelle Bedrosian, Constance T. Albarracin, Carlos Hernando Barcenas, Vicente Valero, Jennifer Keating Litton y Debu Tripathy. "Outcome of patients with breast cancer and a germline BRCA mutation in a prospective cohort." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): 1544. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1544.
Texto completoAkaev, Iolia, Siavash Rahimi, Olubukola Onifade, Francis John Edward Gardner, David Castells-Rufas, Eleanor Jones, Shyamika Acharige y Chit Cheng Yeoh. "Tumour Versus Germline BRCA Testing in Ovarian Cancer: A Single-Site Institution Experience in the United Kingdom". Diagnostics 11, n.º 3 (19 de marzo de 2021): 547. http://dx.doi.org/10.3390/diagnostics11030547.
Texto completoSmith, Wesley, Kayla Smith, William Sessions, Connor Evins, Michael Baker y Mary Blumer. "An evaluation of gender discrepancies in genetic referrals for BRCA testing for indicated malignancies." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): 10584. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10584.
Texto completoOktay, K., J. Kim, D. Barad, N. Gleicher y S. Babayev. "Association of BRCA1 mutations with diminished ovarian reserve: A common genetic mechanism for breast/ovarian cancer, and infertility?" Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): 11039. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.11039.
Texto completoMetcalfe, Kelly A., Aletta Poll, Robert Royer, Marcia Llacuachaqui, Anna Tulman, Ping Sun y Steven A. Narod. "Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women". Journal of Clinical Oncology 28, n.º 3 (20 de enero de 2010): 387–91. http://dx.doi.org/10.1200/jco.2009.25.0712.
Texto completoLindsey, Heather. "BRCA Testing". Oncology Times 26, n.º 3 (febrero de 2004): 12. http://dx.doi.org/10.1097/01.cot.0000291728.63654.be.
Texto completoMirza, M. A., A. Sehbai, T. Nestor, V. Brown y J. Abraham. "BRCA mutations: An Appalachian experience". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 20111. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.20111.
Texto completoPoon, Kok-Siong, Lily Chiu y Karen Mei-Ling Tan. "Laboratory Verification of a BRCA1 and BRCA2 Massively Parallel Sequencing Assay from Wet Bench to Bioinformatics for Germline DNA Analysis". Global Medical Genetics 08, n.º 02 (16 de marzo de 2021): 062–68. http://dx.doi.org/10.1055/s-0041-1726338.
Texto completoHwang, E. Shelley, Jane L. McLennan, Dan H. Moore, Beth B. Crawford, Laura J. Esserman y John L. Ziegler. "Ductal Carcinoma In Situ in BRCA Mutation Carriers". Journal of Clinical Oncology 25, n.º 6 (9 de febrero de 2007): 642–47. http://dx.doi.org/10.1200/jco.2005.04.0345.
Texto completoKeung, Yi-Kong, Adriana Hu, Annie Yeung, Amy Chan y Eddie Hu. "Higher prevalence of BRCA2 mutations among Chinese breast cancer patients in a community oncology clinic." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): e12017-e12017. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e12017.
Texto completoRandall, Megan, Kelly Burgess, Lela Buckingham y Lydia Usha. "Exceptional Response to Olaparib in a Patient With Recurrent Ovarian Cancer and an Entire BRCA1 Germline Gene Deletion". Journal of the National Comprehensive Cancer Network 18, n.º 3 (marzo de 2020): 223–28. http://dx.doi.org/10.6004/jnccn.2019.7378.
Texto completoArun, Banu, Soley Bayraktar, Diane D. Liu, Angelica M. Gutierrez Barrera, Deann Atchley, Lajos Pusztai, Jennifer Keating Litton et al. "Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience". Journal of Clinical Oncology 29, n.º 28 (1 de octubre de 2011): 3739–46. http://dx.doi.org/10.1200/jco.2011.35.2682.
Texto completoManchanda, Ranjit, Li Sun, Shreeya Patel, Olivia Evans, Janneke Wilschut, Ana Carolina De Freitas Lopes, Faiza Gaba et al. "Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems". Cancers 12, n.º 7 (17 de julio de 2020): 1929. http://dx.doi.org/10.3390/cancers12071929.
Texto completoWeitzel, Jeffrey N., Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth et al. "Prevalence and Type ofBRCAMutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network". Journal of Clinical Oncology 31, n.º 2 (10 de enero de 2013): 210–16. http://dx.doi.org/10.1200/jco.2011.41.0027.
Texto completoHowarth, Dt R., Sharon S. Lum, Pamela Esquivel, Carlos A. Garberoglio, Maheswari Senthil y Naveenraj L. Solomon. "Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome". American Surgeon 81, n.º 10 (octubre de 2015): 941–44. http://dx.doi.org/10.1177/000313481508101006.
Texto completoChandrasekaran, Dhivya, Monika Sobocan, Oleg Blyuss, Rowan E. Miller, Olivia Evans, Shanthini M. Crusz, Tina Mills-Baldock et al. "Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study". Cancers 13, n.º 17 (27 de agosto de 2021): 4344. http://dx.doi.org/10.3390/cancers13174344.
Texto completoMetcalfe, Kelly A., Aletta Poll, Andrea Eisen, Jordan Lerner-Ellis y Steven Narod. "Outcomes associated with rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 1577. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.1577.
Texto completoAbida, Wassim, David Campbell, Akash Patnaik, Brieuc Sautois, Jeremy David Shapiro, Nicholas J. Vogelzang, Alan Haruo Bryce et al. "Genomic characteristics associated with clinical activity of rucaparib in patients (pts) with BRCA1 or BRCA2 (BRCA)-mutated metastatic castration-resistant prostate cancer (mCRPC)." Journal of Clinical Oncology 38, n.º 6_suppl (20 de febrero de 2020): 178. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.178.
Texto completoPal, Tuya, Deborah Cragun, Xuefeng Wang, Sean J. Yoder, Tania MESA, Marilin Rosa, Ann Tezak, Anne Weidner, Susan Thomas Vadaparampil y Catherine Phelan. "Characterization of germline and tumor genomic profile in unselected young black breast cancer patients." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): e13090-e13090. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e13090.
Texto completoBahsi, Taha y Haktan Bağış Erdem. "Spectrum of BRCA1/BRCA2 variants in 1419 Turkish breast and ovarian cancer patients: a single center study". Turkish Journal of Biochemistry 45, n.º 1 (24 de diciembre de 2019): 83–90. http://dx.doi.org/10.1515/tjb-2019-0424.
Texto completoGoncalves, Susana Beatriz, Gonzalo Giornelli, Marcelo Horacio Pereira, Dolores Gallardo-Rincon y Maria Del Pilar Estevez-Diz. "FLABRA, frontline approach for BRCA testing in ovarian cancer (OC) treatment naïve population: A Latin America (LA) epidemiologic study." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): e17050-e17050. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e17050.
Texto completoAbida, Wassim, Alan Haruo Bryce, Nicholas J. Vogelzang, Robert J. Amato, Ivor John Percent, Jeremy David Shapiro, Raymond S. McDermott et al. "Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 5031. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.5031.
Texto completoToss, Angela, Marta Venturelli, Eleonora Molinaro, Stefania Pipitone, Elena Barbieri, Isabella Marchi, Elena Tenedini et al. "Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies". Cancers 11, n.º 2 (7 de febrero de 2019): 193. http://dx.doi.org/10.3390/cancers11020193.
Texto completoDi Brino, Eugenio, Matteo Ruggeri, Stefania Boccia, Nicoletta Cerana, Domenica Lorusso, Dario Sacchini, Antonella Savarese, Liliana Varesco y Americo Cicchetti. "A cost-minimization analysis of a preventive testing strategy for relatives of patients with BRCA mutated ovarian cancer". Global & Regional Health Technology Assessment 7, n.º 1 (4 de abril de 2020): 1–8. http://dx.doi.org/10.33393/grhta.2020.557.
Texto completoLipton, Joseph H., Mahdi Zargar, Ellen Warner, Ellen E. Greenblatt, Esther Lee, Kelvin K. W. Chan y William W. L. Wong. "Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations". Human Reproduction 35, n.º 2 (febrero de 2020): 434–45. http://dx.doi.org/10.1093/humrep/dez203.
Texto completoSpizzo, Gilbert, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey, Anthony F. Shields, Sukeshi Patel Arora et al. "Molecular profile of BRCA-mutated biliary tract cancers". ESMO Open 5, n.º 3 (junio de 2020): e000682. http://dx.doi.org/10.1136/esmoopen-2020-000682.
Texto completoHart, Lowell L., Kai Treuner, Li Ma, Jenna Wong, Catherine A. Schnabel y James Andrew Reeves. "Integration of molecular cancer classification and next-generation sequencing to identify metastatic patients eligible for PARP inhibitors." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): e15080-e15080. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e15080.
Texto completo